Key Updates
Boeing shares advanced 2.16% to $235.72 since the May 6 report, approaching the $238 fair value threshold and extending the YTD gain to 8.57%. The momentum reflects sustained delivery execution following Q1 results, though no new material catalysts emerged in the two-day period. The stock has now appreciated 21.12% over six months, consolidating gains from the operational turnaround while trading within 1% of Morningstar's revised fair value estimate.
Current Trend
Boeing maintains a constructive uptrend across all timeframes, with YTD performance of 8.57% and six-month gains of 21.12%. The stock has recovered from the May 4 decline to $223.00, establishing a higher low and demonstrating resilience at the $223-$225 support zone. Current price action at $235.72 represents a 5.7% recovery from the recent trough, with the $238 fair value level serving as immediate resistance. The 8.23% monthly gain and 3.67% five-day advance indicate sustained buying interest, though momentum has moderated from the April surge following Q1 earnings.
Investment Thesis
The investment thesis centers on Boeing's operational recovery through increased aircraft delivery volumes, particularly the 737 MAX program which represents approximately 50% of enterprise value. With Q1 2026 deliveries reaching 143 aircraft (10% year-over-year growth) and a record backlog of $695 billion across 6,100 commercial aircraft, the company is positioned to convert deferred revenue into cash flow as production rates normalize. The thesis depends on three critical factors: achieving 500 annual 737 MAX deliveries, securing FAA certification for the 737 MAX 7 and MAX 10 variants expected in late 2026, and generating positive free cash flow in the second half of 2026 with annual targets of $1-3 billion. The defense segment's 21% revenue growth and $86 billion backlog provide diversification, while the $576 billion commercial backlog offers multi-year revenue visibility.
Thesis Status
The thesis remains intact and on track, with execution progressing as anticipated. Q1 2026 results demonstrated delivery momentum with 143 aircraft shipped and 140 net orders booked, maintaining the order-to-delivery balance necessary for backlog conversion. The company reaffirmed full-year guidance for 500 737 MAX deliveries and positive free cash flow beginning in H2 2026, providing confidence in the recovery timeline. However, the $0.20 core loss per share and negative $1.5 billion free cash flow in Q1 underscore that Boeing remains in the early stages of its turnaround, with profitability dependent on achieving higher production rates. The $238 fair value estimate, reduced from $246 by Morningstar due to slower delivery ramp-up and increased capital requirements, suggests limited upside at current levels. The Bangladesh Airlines order for 14 aircraft and Boeing's Q1 delivery victory over Airbus (143 vs. 114 units) validate demand strength and competitive positioning, supporting the multi-year recovery narrative.
Key Drivers
Boeing's near-term performance hinges on production rate increases, with the 737 MAX program operating at approximately 42 units monthly and awaiting FAA approval to reach 47 units. Regulatory certification for the 737 MAX 7 and MAX 10 variants expected in late 2026 represents a critical catalyst, with deliveries beginning in 2027 to unlock significant backlog value. The company's ability to achieve positive free cash flow in H2 2026 will validate the turnaround thesis and support the stock's valuation. The Biman Bangladesh Airlines order for 14 aircraft demonstrates continued commercial momentum in emerging markets, where Boeing projects South Asia's widebody fleet will triple over 20 years. Defense segment growth, with record backlog reaching $86 billion, provides earnings stability during the commercial recovery phase. Potential large orders from Chinese airlines remain a wildcard that could materially accelerate revenue growth and backlog expansion.
Technical Analysis
Boeing is trading at $235.72, just 1% below the $238 fair value resistance level established by Morningstar's revised estimate. The stock has formed a higher low at $223.00 on May 4, creating a bullish structure above the critical $220-$225 support zone. The 21.12% six-month rally has encountered consolidation near fair value, with the $238 level serving as a key decision point for further upside. Short-term momentum remains positive with the 5-day gain of 3.67% and 1-month advance of 8.23%, though the pace has decelerated from April's surge. The YTD performance of 8.57% lags the six-month gain, indicating the majority of appreciation occurred in late 2025. A sustained break above $238 would target the $245-$250 range, while failure to clear this resistance could trigger consolidation back toward $225-$228 support.
Bull Case
- Record backlog of $695 billion across 6,100 commercial aircraft provides multi-year revenue visibility and supports valuation, with the commercial backlog alone valued at $576 billion representing approximately 6-7 years of production at current delivery rates.
- Management reaffirmed full-year guidance for 500 737 MAX deliveries and positive free cash flow of $1-3 billion beginning in H2 2026, validating the operational recovery timeline and providing a clear path to profitability.
- Boeing delivered 143 aircraft in Q1 2026, surpassing Airbus's 114 deliveries and extending competitive momentum following the 2025 annual sales victory that ended a seven-year losing streak against the European rival.
- Defense segment achieved record backlog of $86 billion with 21% revenue growth to $7.6 billion, providing earnings diversification and stability during the commercial aircraft recovery phase.
- Expected FAA certification of 737 MAX 7 and MAX 10 variants in late 2026 with deliveries beginning in 2027 will unlock significant backlog value and expand the product portfolio to capture additional market segments.
Bear Case
- Morningstar reduced fair value estimate to $238 from $246 due to slower commercial delivery ramp-up and increased long-term capital requirements, indicating the stock trades at full valuation with limited upside at $235.72.
- Q1 2026 generated negative free cash flow of $1.5 billion with cash declining from $29.4 billion to $20.9 billion, demonstrating the company remains cash-consumptive and dependent on production rate increases to achieve profitability.
- Commercial aircraft unit reported operational losses despite 143 deliveries and $9.2 billion in revenue, indicating margin pressure persists even as volumes recover from prior-year levels.
- 737 program represents approximately 50% of enterprise value, creating concentrated risk around production rate increases and regulatory approvals, with current output at 42 units monthly below the 47-unit target awaiting FAA approval.
- Elevated jet fuel costs driven by geopolitical tensions and reduced airline operations amid regional conflict threaten demand for new aircraft and could pressure airline customers to defer or cancel orders.